Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManx Financial Regulatory News (MFX)

Share Price Information for Manx Financial (MFX)

Share Price is delayed by 15 minutes
Get Live Data
23.50    -1.00 (-4.08%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £28.89m
MFX Live PriceLast checked at - London Stock Exchange

Intraday Manx Financial Share Chart

Loan Agreement Extensions

19 Feb 2025 07:00

RNS Number : 5978X
Manx Financial Group PLC
19 February 2025
 

FOR IMMEDIATE RELEASE 19 February 2025

 

Manx Financial Group PLC

 ("Group")

 

Loan Agreement Extension

Unsecured Convertible Loan Agreement Extension

 

 

The Group is pleased to announce the extension for a further five years of an outstanding unsecured loan agreement and an unsecured convertible loan note, together totalling £2.25 million, that were otherwise due for repayment on 25 February 2025 and 26 February 2025 respectively. The loans help underpin the Regulatory Capital required to support lending as directed under the Isle of Man banking licence regulations.

 

The independent directors, being all the directors with the exception of Jim Mellon, Denham Eke and Greg Bailey, have negotiated on standard commercial terms the renewal of the £1.0 million loan from Burnbrae Limited ("Burnbrae Loan"), and the renewal of the £1.25 million convertible loan note from Jim Mellon ("Mellon Loan") Both loans shall accrue interest of 7.5% (previously 5.4%) which will be paid quarterly. The conversion rate for the Mellon Loan continues to be 9 pence per Ordinary Share, adjustable in such manner as will be determined by the Group's auditors for such corporate actions as share subdivisions and consolidations. Jim Mellon has confirmed that he is not seeking to exercise his conversion rights as this may trigger an obligation to make a general offer under Rule 9 of the Takeover Code.

 

AIM Rule 13

 

As Jim Mellon and Denham Eke are both directors, and Jim Mellon is the 100% beneficial owner, of Burnbrae Limited, the provision of the Burnbrae Loan and the Mellon Loan are Related Party Transactions under the AIM Rules. Accordingly, the independent directors, being Douglas Grant, Greg Jones, John Spellman and James Smeed, consider, after consulting the Group's Nominated Adviser, that the terms of the Burnbrae Loan and Mellon Loan are fair and reasonable insofar as the Group's shareholders are concerned. In forming this view the independent director's took note of the favourable interest rate on the loans when compared to current market rates.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

 

For further information, please contact:

 

Manx Financial Group PLC

Denham Eke

Executive Vice Chair

Tel: +44 (0) 1624 694694

 

Beaumont Cornish Limited

Roland Cornish/James Biddle

Tel: +44 (0) 20 7628 3396

 

Greentarget Limited

Jamie Brownlee

Tel: +44 (0) 20 3307 5726

 

 

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFVLLFELLBBBX
Date   Source Headline
21st Sep 20237:00 amRNSUnaudited Interim Results to 30 June 2023
17th Jul 20232:24 pmRNSUpdate regarding Issue of Ordinary Shares
12th Jul 20237:00 amRNSIssue of Shares pursuant to Scrip Dividend & TVR
19th Jun 20237:00 amRNSScrip Share Price
30th May 202312:30 pmRNSResult of AGM and Dividend Declaration
5th May 20237:00 amRNSNotice of AGM
21st Mar 20237:00 amRNSFinal Results
15th Dec 202212:37 pmRNSHolding(s) in Company
12th Dec 20226:12 pmRNSHolding(s) in Company
27th Oct 20229:00 amRNSGrant of Restricted Share Units
27th Oct 20227:00 amRNSConister applies for UK Branch banking licence
27th Sep 20227:00 amRNSInterim Results for the 6 months to 30 June 2022
21st Sep 20227:00 amRNSAcquisition of 50.1% interest in Payment Assist
22nd Jul 20227:00 amRNSExtension of Unsecured Convertible Loan Notes
7th Jul 20227:00 amRNSGrant of Restricted Share Units
23rd Jun 20229:01 amRNSPrice Monitoring Extension
17th Jun 202212:42 pmRNSNew Shares issued pursuant to Scrip Dividend, TVR
9th Jun 20227:00 amRNSScrip Share Price
26th May 20227:00 amRNSConister Bank Limited appoints new Chairman
25th May 202212:16 pmRNSResult of AGM & Dividend Declaration
16th May 20227:00 amRNSConditional Acquisition of 50.1% interest in PAL
29th Apr 20228:00 amRNS2022 Annual General Meeting
10th Mar 20227:00 amRNSReport and Accounts for the year ended 31 Dec 2021
11th Jan 20223:54 pmRNSChange to Director Holdings
11th Jan 20229:39 amRNSChange to Director Holdings
4th Nov 20217:00 amRNSChanges to Group Boards
11th Oct 20217:00 amRNSAcquisition of Additional 60% Shareholding in BLX
29th Sep 202112:00 pmRNSUnaudited Interim Results to 30 June 2021
3rd Sep 20217:00 amRNSTotal Voting Rights
24th Aug 202110:39 amRNSFurther UK Government-backed lending accreditation
13th Aug 20217:00 amRNSDirector/PDMR Shareholding
6th Aug 20217:00 amRNSIssue of Ordinary Shares and TVR
21st Jul 20217:00 amRNSScrip Share Price
7th Jul 202112:05 pmRNSResult of EGM and Dividend Declaration
15th Jun 20217:00 amRNSNotice of EGM
14th Jun 20217:00 amRNSAcquisition of Additional Shareholding in BSL
9th Jun 20217:00 amRNSAcquisition of Shareholding in Rivers Finance
4th Jun 20217:00 amRNSMFX ENTERS THE SME DEBT MANAGEMENT MARKET
3rd Jun 20217:00 amRNSResult of AGM
5th May 20217:00 amRNSNotice of AGM
4th Mar 20217:00 amRNSReport and Accounts to 31 December 2020
14th Jan 20217:00 amRNSGovernment-backed lending increase
23rd Dec 20207:00 amRNSDividend Scheme Announced
15th Oct 20207:00 amRNSManx Financial raises £2m of additional capital
28th Aug 20207:00 amRNSHalf-year Report
21st Aug 20207:00 amRNSGovernment Lending Schemes
7th Aug 20202:04 pmRNSResult of AGM
15th Jul 20207:00 amRNSNotice of AGM
30th Jun 20207:00 amRNSFinal Results
4th Jun 202010:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.